|Finkelstein Thompson LLP Investigates Stryker’s Rejuvenate and ABG II Hip Implant Systems|
July 18, 2012
Finkelstein Thompson LLP is investigating a recent recall by Stryker of their Rejuvenate and ABG II modular-neck-stem hip implant systems due to reported adverse side effects. Stryker’s official website cites “fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reactions manifesting with pain and/or swelling” as the reason for the recall. According to published reports, the recall was made after post-marking surveillance that may be predictive of a trend.
The Stryker Rejuvenate and ABG II modular-neck hip stems can be used as a component of either metal or ceramic hip implants, with the metal-on-metal modular junction subject to metallic collision, which may cause toxic metal debris to loosen and enter the bloodstream. Due to this side effect, some patients who received the Rejuvenate and ABG II modular neck-implants have experienced swelling, corrosion, fretting of the joints, and have even developed Metallosis—a painful condition caused by severe amounts of metal in the bloodstream.
Medical experts in the United States have been studying the potential dangers of metal hip replacement systems. The FDA recently convened a panel of experts to weigh in on the safety of metal-on-metal hip implants, where they ultimately cautioned doctors against using the devices. Furthermore, there have reportedly been at least 45 adverse events reported to the FDA regarding the Rejuvenate modular-neck stem since the beginning of 2012.